Aashish
@aashish.ra.3571
Delhi
3+ Years of experience
SEBI Registration INH000013174I'm Aashish, a Delhi-based stock and Futures and Options specialist with 3+ years of market experience.
Trade Ideas
513
Opinions
661
Followers
110k
Expertise
Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 20 mins ago
Kirlpnu Industrial Compressors, Refrigeration & Gas Systems
KIRLPNU
Strengths
- Established industrial compressor manufacturer.
- Strong engineering and manufacturing capabilities.
- Presence in refrigeration and gas compression.
- Diversified industrial customer base.
- Healthy historical profitability.
- Strong FY26 order inflow above ₹2,000 Cr.
- Growing technology and intellectual-property portfolio.
Weaknesses
- Q2 FY27 revenue declined 15.6%.
- Export dispatch delays affected sales.
- High dependence on compression business.
- Industrial order execution can be lumpy.
- EBITDA and profit affected by lower sales volumes.
- Exposure to working-capital requirements.
Opportunities
- Growth in industrial infrastructure.
- Demand from oil, gas and energy sectors.
- Industrial refrigeration expansion.
- Export-market opportunities.
- New compressor technologies.
- Strategic partnership with Kobe Steel.
- Strong order book provides future revenue visibility.
Threats
- Global economic slowdown.
- Competition from international compressor manufacturers.
- Raw-material price fluctuations.
- Shipping and geopolitical disruptions.
- Delayed customer project execution.
- Lower industrial capex.
- Foreign-exchange fluctuations.
shared an insight ⚡️ 6 hours ago
NEOGEN CHEMICALS
Specialty Chemicals & Battery Materials
NEOGEN
Strengths
- Strong presence in specialty chemicals.
- Expertise in lithium and organolithium products.
- Growing battery chemicals business.
- Revenue growth of 42% in Q2 FY27.
- Strong customer relationships and technical capabilities.
- QIP fundraising strengthens financial flexibility.
Weaknesses
- High capital expenditure requirements.
- Consolidated PAT remains relatively low.
- High interest and depreciation expenses.
- Battery business still in capacity-ramp-up stage.
- Dahej facility disruption affected operations.
- Low profitability compared with revenue scale.
Opportunities
- Growing EV and lithium-ion battery market.
- Battery electrolyte and lithium salts demand.
- India's domestic battery manufacturing expansion.
- Organolithium applications in pharmaceuticals and chemicals.
- New Dahej SEZ and Pakhajan facilities.
- Potential operating leverage as capacity utilisation improves.
Threats
- Competition from Chinese chemical manufacturers.
- Lithium raw-material price volatility.
- Geopolitical and supply-chain disruptions.
- Delays in EV and battery projects.
- High debt and interest-cost pressure.
- Customer concentration and technology risks.
- Facility shutdowns or regulatory issues.
shared an insight ⚡️ 20 hours ago
ENTERO HEALTHCARE SOLUTIONS – SWOT ANALYSIS
ENTERO
Strengths
- Strong pharmaceutical distribution network.
- High revenue growth in Q2 FY27.
- Improving EBITDA and profit margins.
- Wide hospital, pharmacy and healthcare customer base.
- Presence across pharmaceutical and medical products.
- Acquisition-led expansion opportunities.
Weaknesses
- Low operating margins compared with pharmaceutical manufacturers.
- High working-capital requirements.
- Dependence on inventory and credit management.
- Acquisition integration challenges.
- Interest expenses and funding requirements.
- Profitability can be affected by distribution costs.
Opportunities
- Growing Indian healthcare and pharmaceutical market.
- Expansion into medical devices and MedTech.
- Hospital and pharmacy network expansion.
- Growth through strategic acquisitions.
- Digital supply-chain and distribution efficiency.
- Management expects FY27 growth and margins to exceed its initial guidance.
*****
Threats
- Competition from established distributors.
- Pricing pressure and low-margin business model.
- Delayed customer payments and bad debts.
- Regulatory changes in pharmaceutical distribution.
- Integration risks from acquisitions.
- Inventory losses and working-capital stress.
- A subsidiary reported a customer payment default of ₹11.87 Cr; full provision was made and recovery action initiated.
FolioPulse
3. Important points to monitor
- Revenue growth above 20%.
- EBITDA margin improvement.
- Operating cash-flow generation.
- Debt and interest-cost movement.
- Working-capital cycle.
- Acquisition performance.
- Recovery of overdue customer payments.
4. Overall view
Positive growth momentum
- Strong revenue and profit growth in Q2 FY27.
- Improving operating margins are encouraging.
- Healthcare distribution offers long-term growth potential.
- Key concern: Low margins, working capital and acquisition execution.
FAQ's
What are the top stock recommendations by Aashish?
Aashish regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include KIRLPNU, NEOGEN and ENTERO. Explore Aashish's complete list of posts and trade views on their StockGro profile.
How can I follow Aashish's latest investment insights?
You can follow Aashish's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Aashish's investment strategy?
Aashish follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Aashish been a SEBI-registered Research Analyst (RA)?
Aashish has been a SEBI-registered Research Analyst and have 3+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Aashish's past performance and stock picks?
You can check Aashish's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Aashish for stock market advice?
For stock market guidance from Aashish, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Aashish's track record in predicting market movements?
Aashish has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Aashish?
Aashish is a SEBI-registered Research Analyst with the SEBI Registration INH000013174. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro